# FDA recall D-406-2013

> **FVS Holdings, Inc. dba. Green Valley Drugs** · Class II · drug recall initiated 2013-04-10.

## Product

Nandrolone Decanoate and Testosterone Cypionate Injection, all strengths and all presentations including a) Nandrolone 100 mg/mL TestCyp 100 mg/mL 10 mL and b) Nandrolone 100 mg/mL TestCyp 200 mg/mL 10 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.

## Reason for recall

Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-406-2013
- **Recalling firm:** FVS Holdings, Inc. dba. Green Valley Drugs
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-04-10
- **Report date:** 2013-05-22
- **Termination date:** 2014-03-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Henderson, NV, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-406-2013

## Citation

> AI Analytics. FDA recall D-406-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-406-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
